The number of people with susceptibility test result for rifampicin in Ghana
Ghana: The number of people with susceptibility test result for rifampicin was 96.1 in 2021. ▬ Flat
Latest (2021)
96.1
Change on year
down 3.9%
World rank
49th
of 146 countries
All-time high
100
in 2019
All-time low
93.49
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Ghana, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Ghana stood at 96.1.
Compared with earlier readings it is down 3.9% on the previous year and down 3.6% over five years.
That places Ghana 49th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Ghana, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 99.65 | — |
| 2018 | 93.49 | -6.2% |
| 2019 | 100 | +7.0% |
| 2020 | 100 | +0.0% |
| 2021 | 96.1 | -3.9% |
Ghana compared with similar countries
- Ghana's 96.1 is above the median for lower middle income countries, which is 78.77, 1.2× the median. (32 countries reporting)
- Ghana's 96.1 is above the median for Sub-Saharan Africa, which is 61.16, 1.6× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 97.71 | 93.49 | 100 | 3 |
| 2020s | 98.05 | 96.1 | 100 | 2 |
Countries ranked near Ghana
More health data for Ghana
- Un projection of annual infant deaths, annual growth rate -1.37 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6224 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 986.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,361 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 0.5623 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.06 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5816 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Ghana?
- The number of people with susceptibility test result for rifampicin in Ghana was 96.1 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Ghana?
- The highest recorded value was 100 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Ghana?
- The lowest recorded value was 93.49 in 2018.
- How does Ghana rank for the number of people with susceptibility test result for rifampicin?
- Ghana ranks 49th out of 146 countries with data for 2021.
- Where does this Ghana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).